MEDVi vs Mochi Health: Medication and Membership Cost Breakdown

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

MEDVi and Mochi Health take opposite approaches to pricing transparency and cost structure. MEDVi charges a single monthly fee that rises after the first month—$179 for compounded semaglutide injections in month one, then $299 every month after—and holds that rate regardless of dose. Mochi Health separates medication ($60/month for starting-dose semaglutide) from membership ($39/month in the first month, with the ongoing rate not publicly displayed) and increases medication cost as dose rises, making the total ongoing cost difficult to project without dose-specific pricing. Over twelve months at standard refill rates, MEDVi's semaglutide injection costs $3,468 when the first-month discount is included, and $3,588 without it. Mochi's starting-dose semaglutide totals $99 in month one, but we could not capture intermediate or maintenance-dose pricing, so a twelve-month calculation is not possible. PlexusDx charges $189/month for compounded semaglutide injection with no membership fee, no first-month discount, and the same rate at every dose—$2,268 over twelve months.

At-a-glance comparison: MEDVi vs Mochi Health vs PlexusDx

All pricing captured September 4, 2026. MEDVi and Mochi Health figures verified at checkout or intake; PlexusDx figures from live product pages. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

What each program costs over twelve months

MEDVi's pricing is straightforward once you understand the two-tier structure: a lower introductory rate for the first order, then a fixed refill rate that does not change with dose. Compounded semaglutide injections cost $179 in the first month and $299 every month after. Over twelve months, that works out to $179 plus eleven refills at $299 each, or $3,468 total (our calculation, captured September 4, 2026). Without the first-month discount, the cost would be $3,588. Compounded tirzepatide injections follow the same pattern: $279 in month one, $399 for refills, totaling $4,668 over twelve months when the first-month rate is included (our calculation). MEDVi also offers compounded semaglutide in oral tablet form, which adds a $70 monthly surcharge over the injection price—$249 in the first month, then $369 per refill—but the tablet option was not the focus of our checkout verification.

Mochi Health's structure makes twelve-month cost projection impossible with the evidence we captured. The program separates medication from membership: compounded semaglutide medication starts at $60/month, compounded tirzepatide at $90/month, and membership was advertised at $39/month for the first month (captured September 4, 2026). We did not capture the ongoing membership rate after month one, and—more importantly—Mochi uses per-dose pricing that increases as your clinician raises your dose. The $60 and $90 figures apply only to starting doses; intermediate and maintenance-dose pricing was not displayed at intake. At the advertised starting dose, Mochi's first-month total is $99 for semaglutide ($60 medication + $39 membership) and $129 for tirzepatide ($90 medication + $39 membership), but those figures do not represent the cost you will pay once your dose is titrated upward.

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection, both on a month-to-month basis with no membership fee and no introductory discount (pricing current as of September 5, 2026). The rate holds at every dose. Over twelve months, semaglutide costs $2,268 and tirzepatide costs $3,468 (our calculation). PlexusDx also offers multi-month commitments that lower the per-month cost: semaglutide drops to $169/month on a three-month plan and $149/month on a six-month plan, prepaid.

Membership vs all-in-one billing

The structural difference between MEDVi and Mochi Health matters most when you try to budget for ongoing treatment. MEDVi rolls clinical support, medication, and shipping into a single monthly charge. You see one line item on your statement—$299 for semaglutide refills, $399 for tirzepatide—and dose increases do not change that figure. Mochi Health separates medication from membership, which means two line items every month and an escalating medication cost as your provider adjusts your dose upward. The separation gives Mochi flexibility to price each dose independently, but it makes long-term cost forecasting harder unless you know your maintenance dose and its specific price.

Neither program requires a contract; both bill monthly. MEDVi's checkout flow showed clear refill pricing and confirmed that dose escalation does not trigger a surcharge (verified September 4, 2026). Mochi's intake displayed starting-dose medication pricing and first-month membership, but did not show the per-dose schedule beyond the starting tier or the post-introductory membership rate. If you choose Mochi, confirm the ongoing membership fee and ask for the medication cost at your expected maintenance dose before committing.

Oral vs injection routes

MEDVi offers compounded semaglutide in both injection and oral tablet form. The oral tablet adds a $70 monthly surcharge over the injection price, bringing the first month to $249 and refills to $369 (our calculation, based on the stated surcharge; captured September 4, 2026). MEDVi also advertises compounded tirzepatide in injection and oral forms; checkout did not display a separate oral surcharge for tirzepatide, but readers should confirm route pricing at checkout since semaglutide oral does carry a premium.

Mochi Health's captured pricing and checkout verification covered injection routes only. The program advertises branded medication pathways, but we did not verify branded pricing or oral route availability in this research pass.

PlexusDx offers compounded semaglutide and tirzepatide in both injection and oral capsule forms. Oral semaglutide costs $289/month (month-to-month) and oral tirzepatide costs $349/month (month-to-month), with multi-month discounts available. The oral capsule formulation may suit patients with needle aversion or those traveling frequently.

Review profiles: service quality and responsiveness

Mochi Health holds a 4.5-star Trustpilot rating across approximately 18,000 reviews (captured September 4, 2026). MEDVi holds a 4.3-star rating across approximately 15,000 reviews (same capture date). PlexusDx holds a 4.2-star rating, with 76 percent of reviews at five stars and 81 percent at four stars or higher (captured September 4, 2026). Individual Trustpilot reports mentioning Mochi described instances of providers appearing late to virtual appointments and not engaging substantively with patient questions; these are isolated anecdotes and not verified as representative patterns. The high volume and ratings of both MEDVi and Mochi suggest broad satisfaction, but any program with thousands of reviews will surface occasional service complaints. Readers should review recent feedback on Trustpilot and consider their own tolerance for variability in clinician interaction style and scheduling reliability.

Choose MEDVi if…

You want certainty about monthly cost after the first refill and prefer a single line item that includes medication, clinical support, and shipping. MEDVi's $299 semaglutide refill rate and $399 tirzepatide refill rate stay fixed regardless of dose, which simplifies budgeting once you are past the introductory month. The program suits patients who plan to stay on a compounded GLP-1 for an extended period and value transparent, dose-invariant pricing. The first-month discount lowers the barrier to starting, but the refill rate is the figure that matters for long-term planning.

Choose Mochi Health if…

You expect to remain at or near a starting dose for several months and want the lowest possible entry cost. Mochi's $60 starting-dose semaglutide medication plus $39 first-month membership totals $99, which is the lowest first-month figure in this comparison. However, the per-dose model means your medication cost will rise as your clinician increases your dose, and the ongoing membership rate after month one was not captured in our research. Mochi is a reasonable choice if you prioritize a low initial out-of-pocket cost and are comfortable confirming escalating dose prices with the program before each refill. The high Trustpilot rating and large review volume suggest strong overall satisfaction, though individual reports note occasional variability in provider engagement.

Where PlexusDx fits

PlexusDx charges $189/month for compounded semaglutide injection and $289/month for compounded tirzepatide injection, both month-to-month with no membership fee and no first-month discount. The rate holds at every dose, which removes the uncertainty inherent in Mochi's per-dose model and avoids the refill jump present in MEDVi's two-tier structure. Over twelve months, PlexusDx semaglutide costs $2,268—$1,200 less than MEDVi's refill-rate total and a calculable figure where Mochi's escalating dose pricing makes projection impossible (our calculation, current as of September 5, 2026). The program includes the online provider visit, prescription, compounded medication, and shipping in every order. Multi-month plans lower the per-month cost further: three-month semaglutide is $169/month prepaid, six-month is $149/month prepaid. PlexusDx also offers oral capsule formulations for patients who prefer to avoid injections, and a microdose semaglutide injection protocol at $129/month for maintenance or patients starting at a sub-therapeutic dose. Every PlexusDx order ships from a licensed 503A compounding pharmacy, and a licensed provider reviews your intake before any prescription is written.

Methodology and freshness

All MEDVi and Mochi Health pricing was captured September 4, 2026, through checkout-verification (intake completed to the point immediately before payment authorization). PlexusDx pricing was captured from live product pages on September 5, 2026. Review ratings and volumes were captured from Trustpilot on September 4, 2026. Twelve-month cost figures for MEDVi and PlexusDx are our calculations, derived by multiplying monthly rates by twelve or by adding the first-month introductory rate to eleven refills. Mochi Health's twelve-month cost could not be calculated because medication pricing is dose-dependent and only starting-dose figures were captured; the ongoing membership rate after the first month was also not captured. Readers should confirm all pricing, route availability, dose-specific costs, and ongoing membership fees at checkout before purchasing. We do not guarantee eligibility, medication availability, or dose assignments; a licensed clinician makes those determinations after reviewing your intake.

Frequently Asked Questions

Does MEDVi charge more when my semaglutide dose increases?

No. MEDVi's pricing is dose-invariant. Once you move past the first-month introductory rate, compounded semaglutide costs $299/month and compounded tirzepatide costs $399/month regardless of dose, verified at checkout September 4, 2026.

Does Mochi Health's $60 semaglutide rate apply at maintenance doses?

No. Mochi's $60/month semaglutide figure is the starting-dose medication cost. The program uses per-dose pricing, so your medication cost rises as your clinician increases your dose. Intermediate and maintenance-dose pricing was not displayed at intake; confirm dose-specific costs before refilling.

What is Mochi Health's membership fee after the first month?

Our research captured the first-month membership rate of $39/month but did not capture the ongoing rate. Confirm the post-introductory membership fee at checkout or by contacting Mochi support before committing to treatment.

Does PlexusDx charge a membership fee or require a contract?

PlexusDx charges no membership fee and requires no contract. The month-to-month plans bill monthly and can be paused or canceled at any time. Multi-month plans (three-month and six-month) are prepaid commitments that lower the per-month cost.

Are compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient, and all compounded medications discussed in this article are prepared by licensed compounding pharmacies.

Sources

• PlexusDx product pages (semaglutide injection, tirzepatide injection, semaglutide oral, tirzepatide oral, microdose GLP-1), accessed September 5, 2026
• MEDVi checkout verification and pricing capture, accessed September 4, 2026
• Mochi Health intake and pricing capture, accessed September 4, 2026
• Trustpilot profiles for MEDVi, Mochi Health, and PlexusDx, accessed September 4, 2026
• Internal PlexusDx pricing documentation, updated September 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.